Crinetics Pharmaceuticals Inc $CRNX

Recent News (7)

• Crinetics Pharmaceuticals stock hits all-time high at 84.8 USD Investing.com · 24 Aug 2026 Crinetics Pharmaceuticals stock hits all-time high at 84.8 USD
• Are ACA, CRNX, LEG Obtaining Fair Deals for their Shareholders? PR Newswire · 03 Aug 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholder…
• Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update GlobeNewswire · 03 Aug 2026 Announced Vertex Agreement to Acquire Crinetics for Total Equity Value of Approximately $10.0 Billion, or Approximately $8.8B Net of Estimated Cash Acquired
• $HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--ACA, CRNX, LEG, and LPSN PR Newswire · 03 Aug 2026 NEW YORK, Aug. 3, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is re…
• Are UTZ, CRNX, SOLS Obtaining Fair Deals for their Shareholders? PR Newswire · 28 Jul 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholder…
• $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG PR Newswire · 23 Jul 2026 NEW YORK, July 23, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is r…
• Are CRNX, VEEE, NXTC, TCBK Obtaining Fair Deals for their Shareholders? PR Newswire · 21 Jul 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholder…